Tagrisso (Osimertinib)
Tagrisso (Osimertinib)
Tagrisso (Osimertinib) is a cancer therapy designed for patients with specific types of non-small cell lung cancer (NSCLC). As a third-generation tyrosine kinase inhibitor (TKI), Tagrisso selectively inhibits the epidermal growth factor receptor (EGFR) with T790M mutation, providing an effective treatment option for patients who have developed resistance to earlier-generation EGFR inhibitors.Why Choose Tagrisso (Osimertinib)?
- Targeted Treatment: Specifically designed to target and inhibit the EGFR T790M mutation, ensuring precision therapy.
- Improved Survival Rates: Demonstrates a significant improvement in progression-free survival (PFS) compared to previous treatments.
- Brain Penetration: Effective in treating brain metastases due to its ability to cross the blood-brain barrier.
- Convenient Oral Administration: Administered as a once-daily oral tablet, simplifying the treatment regimen.
- Enhanced Quality of Life: Helps in managing symptoms and improving patients' overall quality of life.
How to Use Tagrisso (Osimertinib)?
- Consult Your Oncologist: Ensure a qualified healthcare provider prescribes Tagrisso.
- Follow Dosage Instructions: Take the exact dosage as directed by your doctor, typically once daily.
- Do Not Crush or Split Tablets: Swallow the tablet whole with water; do not crush, split, or chew.
- Regular Monitoring: Attend all scheduled appointments for blood tests and scans to monitor the treatment's progress.
- Manage Side Effects: Report any side effects to your healthcare provider promptly.
- Store Properly: Keep Tagrisso in its original packaging at room temperature, away from moisture and heat.
- Adherence: Do not miss doses. If a dose is missed, take it as soon as you remember unless it is almost time for the next dose.
Important Safety Information about Tagrisso
- Allergies: Inform your doctor of any allergies, especially to Osimertinib or any other medications.
- Medical History: Disclose your complete medical history, particularly any history of lung or breathing problems, heart issues, or liver disease.
- Pregnancy and Breastfeeding: Avoid use if you are pregnant or breastfeeding. Discuss potential risks with your doctor.
- Drug Interactions: Inform your healthcare provider about all other medications and supplements you are taking to avoid potential interactions.
Fact Table
| Facts | Details |
| Product Name | Tagrisso (Osimertinib) |
| Drug Class | Tyrosine Kinase Inhibitor (TKI) |
| Indications | Non-Small Cell Lung Cancer (NSCLC) with EGFR mutations |
| Mechanism of Action | Inhibits EGFR (Epidermal Growth Factor Receptor) tyrosine kinase, including T790M mutation, leading to inhibition of tumor cell growth |
| Dosage Form | Tablet |
| Strengths Available | 40 mg, 80 mg |
| Administration | Oral, once daily, with or without food |
| Common Side Effects | - Diarrhea - Rash - Dry skin - Nail toxicity - Cough |
| Contraindications | - Known hypersensitivity to osimertinib or any of its components |
| Monitoring Parameters | - Lung function (for interstitial lung disease) - ECG (for QT prolongation) - Ejection fraction (for cardiomyopathy) - Eye exams (for keratitis) |
| Special Populations | - Pregnancy: Can cause fetal harm - Breastfeeding: Not recommended - Pediatric: Safety and efficacy not established |
| Storage | Store at room temperature (20-25°C or 68-77°F), protect from moisture |
| Important Notes | - Regular follow-up and monitoring are essential - Report any unusual symptoms or side effects to your healthcare provider immediately |
Common Side Effects
Like all medications, Tagrisso (Osimertinib) can cause side effects, although not everybody gets them. Understanding these side effects can help you use this medication safely and effectively.- Diarrhea
- Rash
- Dry skin
- Nail toxicity
- Cough
How Can You Buy Tagrisso (Osimertinib)?
You can order Tagrisso (Osimertinib) using these methods on our website:- Order Online
- Order by Phone
- Order by Fax
- Order your refills
